Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved…
STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…
SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company advancing small-molecule inhibition of…
Introduction of AVT05 supported by NHS England tender award in the United Kingdom REYKJAVIK, Iceland, Dec. 22, 2025 (GLOBE NEWSWIRE)…
LAKELAND, Dec. 20, 2025 (GLOBE NEWSWIRE) -- This educational analysis is sponsored by Health Journey, a dietary supplement company whose…
December 19, 2025 18:10 ET | Source: Vireo Growth Inc. MINNEAPOLIS, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc.…
IRVINE, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical…
DALLAS, Dec. 20, 2025 (GLOBE NEWSWIRE) -- In PDF https://bit.ly/437YX7H) The Crosetto Foundation for the Reduction of Cancer Deaths, a…
Clemson University and Nordic Wellness have launched a pioneering partnership tackling the student mental health crisis through peer-led cold plunging…
Los Angeles, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Important Information for Readers: This article is for informational purposes only and…